Hostname: page-component-586b7cd67f-t8hqh Total loading time: 0 Render date: 2024-11-26T08:03:22.427Z Has data issue: false hasContentIssue false
  • English
  • Français

Rates of diagnostic transition and cognitive change at 18-month follow-up among 1,112 participants in the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing (AIBL)

Published online by Cambridge University Press:  20 November 2013

Kathryn A. Ellis ,
Cassandra Szoeke ,
Ashley I. Bush ,
David Darby ,
Petra L. Graham ,
Nicola T. Lautenschlager ,
S. Lance Macaulay ,
Ralph N. Martins ,
Paul Maruff  and
Colin L. Masters
...Show all authors
Kathryn A. Ellis*
Affiliation:
Academic Unit for Psychiatry of Old Age, Department of Psychiatry, University of Melbourne; St. Vincent's Aged Psychiatry Service, St George's Hospital, Kew, Victoria, Australia Florey Institute of Neuroscience and Mental Health (MHRI), Parkville, Victoria, Australia National Ageing Research Institute (NARI), Parkville, Victoria, Australia
Cassandra Szoeke
Affiliation:
National Ageing Research Institute (NARI), Parkville, Victoria, Australia Commonwealth Scientific and Industrial Research Organisation, Preventative Health Flagship, CMSE CMIS (CSIRO), Parkville, Victoria, Australia
Ashley I. Bush
Affiliation:
Florey Institute of Neuroscience and Mental Health (MHRI), Parkville, Victoria, Australia
David Darby
Affiliation:
Florey Institute of Neuroscience and Mental Health (MHRI), Parkville, Victoria, Australia
Petra L. Graham
Affiliation:
Macquarie University, Sydney, NSW, Australia
Nicola T. Lautenschlager
Affiliation:
Academic Unit for Psychiatry of Old Age, Department of Psychiatry, University of Melbourne; St. Vincent's Aged Psychiatry Service, St George's Hospital, Kew, Victoria, Australia School of Psychiatry and Clinical Neurosciences and WA Centre for Health and Ageing, University of Western Australia, Crawley, WA, Australia
S. Lance Macaulay
Affiliation:
Commonwealth Scientific and Industrial Research Organisation, Preventative Health Flagship, CMSE CMIS (CSIRO), Parkville, Victoria, Australia
Ralph N. Martins
Affiliation:
Sir James McCusker Alzheimer's Disease Research Unit (Hollywood Private Hospital), Perth, WA, Australia
Paul Maruff
Affiliation:
CogState Limited, Melbourne, Victoria, Australia
Colin L. Masters
Affiliation:
Florey Institute of Neuroscience and Mental Health (MHRI), Parkville, Victoria, Australia
Simon J. McBride
Affiliation:
Commonwealth Scientific and Industrial Research Organisation, Preventative Health Flagship, CMSE CMIS (CSIRO), Parkville, Victoria, Australia
Kerryn E. Pike
Affiliation:
Latrobe University, Melbourne, Victoria, Australia
Stephanie R. Rainey-Smith
Affiliation:
Sir James McCusker Alzheimer's Disease Research Unit (Hollywood Private Hospital), Perth, WA, Australia
Alan Rembach
Affiliation:
Florey Institute of Neuroscience and Mental Health (MHRI), Parkville, Victoria, Australia
Joanne Robertson
Affiliation:
Florey Institute of Neuroscience and Mental Health (MHRI), Parkville, Victoria, Australia
Christopher C. Rowe
Affiliation:
Department of Nuclear Medicine and Centre for PET, Austin Health, Heidelberg, Victoria, Australia Department of Medicine, University of Melbourne; Austin Health, Heidelberg, Victoria, Australia
Greg Savage
Affiliation:
Macquarie University, Sydney, NSW, Australia
Victor L. Villemagne
Affiliation:
Florey Institute of Neuroscience and Mental Health (MHRI), Parkville, Victoria, Australia Department of Nuclear Medicine and Centre for PET, Austin Health, Heidelberg, Victoria, Australia
Michael Woodward
Affiliation:
Austin Health, Aged Care, Heidelberg, Victoria, Australia
William Wilson
Affiliation:
Commonwealth Scientific and Industrial Research Organisation, Preventative Health Flagship, CMSE CMIS (CSIRO), Parkville, Victoria, Australia
Ping Zhang
Affiliation:
Commonwealth Scientific and Industrial Research Organisation, Preventative Health Flagship, CMSE CMIS (CSIRO), Parkville, Victoria, Australia
David Ames
Affiliation:
Academic Unit for Psychiatry of Old Age, Department of Psychiatry, University of Melbourne; St. Vincent's Aged Psychiatry Service, St George's Hospital, Kew, Victoria, Australia National Ageing Research Institute (NARI), Parkville, Victoria, Australia
*
Correspondence should be addressed to: Kathryn A. Ellis, Academic Unit for Psychiatry of Old Age, Department of Psychiatry, University of Melbourne, 155 Oak Street Parkville, VIC 3052, Australia. Phone: +61-39389-2919; Fax: +61-39387-5061. Email: [email protected].
Get access Rights & Permissions [Opens in a new window]

Abstract

Background:

The Australian Imaging, Biomarkers and Lifestyle (AIBL) Flagship Study of Ageing is a prospective study of 1,112 individuals (211 with Alzheimer's disease (AD), 133 with mild cognitive impairment (MCI), and 768 healthy controls (HCs)). Here we report diagnostic and cognitive findings at the first (18-month) follow-up of the cohort. The first aim was to compute rates of transition from HC to MCI, and MCI to AD. The second aim was to characterize the cognitive profiles of individuals who transitioned to a more severe disease stage compared with those who did not.

Methods:

Eighteen months after baseline, participants underwent comprehensive cognitive testing and diagnostic review, provided an 80 ml blood sample, and completed health and lifestyle questionnaires. A subgroup also underwent amyloid PET and MRI neuroimaging.

Results:

The diagnostic status of 89.9% of the cohorts was determined (972 were reassessed, 28 had died, and 112 did not return for reassessment). The 18-month cohort comprised 692 HCs, 82 MCI cases, 197 AD patients, and one Parkinson's disease dementia case. The transition rate from HC to MCI was 2.5%, and cognitive decline in HCs who transitioned to MCI was greatest in memory and naming domains compared to HCs who remained stable. The transition rate from MCI to AD was 30.5%.

Conclusion:

There was a high retention rate after 18 months. Rates of transition from healthy aging to MCI, and MCI to AD, were consistent with established estimates. Follow-up of this cohort over longer periods will elucidate robust predictors of future cognitive decline.

Keywords

Alzheimer's diseasemild cognitive impairmenthealthy controlscohort studylongitudinal studyPiB PET imagingAIBLAustralian ADNI
Type
Research Article
Information
International Psychogeriatrics , Volume 26 , Issue 4 , April 2014 , pp. 543 - 554
Copyright
Copyright © International Psychogeriatric Association 2013 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

American Psychiatric Association (1994). Diagnostic and Statistical Manual of Mental Health Disorders, 4th edn. Washington, DC: American Psychiatric Association.Google Scholar
Buckley, R. et al. (2013). Cognitive and affective predictors of subjective memory complaints in the Australian Imaging Biomarkers and Lifestyle (AIBL) study of aging: a cross-sectional analysis. International Psychogeriatrics, 7, S239.Google Scholar
Craig, C. L. et al. (2003). International physical activity questionnaire: 12-country reliability and validity. Medicine and Science in Sports and Exercise, 35, 1381–1395.Google Scholar
Delis, D., Kramer, J., Kaplan, E. and Ober, B. (2000). California Verbal Learning Test-Second Edition. San Antonio, TX: The Psychological Corporation.Google Scholar
Delis, D. C., Kaplan, E. and Kramer, J. H. (2001). The Delis-Kaplan Executive Function System (D-KEFS). San Antonio, TX: The Psychological Corporation.Google Scholar
Ellis, K. A. et al. (2009). The Australian Imaging Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease. International Psychogeriatrics, 21, 672–687.Google Scholar
Folstein, M. F., Folstein, S. E. and McHugh, P. R. (1975). “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189–198.Google Scholar
Jorm, A. F. and Jacomb, P. A. (1989). The Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): socio-demographic correlates, reliability, validity and some norms. Psychological Medicine, 19, 1015–1022.Google Scholar
Kurz, A. and Lautenschlager, N. L. (2010). Established treatements for Alzheimer's disease: cholinesterase inhibitors and memantine. In Ames, D., Burns, A. and O'Brien, J. (eds.), Dementia, 4th edn. (pp. 471–483). London: Hodder.Google Scholar
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D. and Stadlan, E. M. (1984). Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology, 34, 939–944.Google Scholar
Mewton, L., Sachdev, P., Anderson, T., Sunderland, M. and Andrews, G. (2013). Demographic, clinical, and lifestyle correlates of subjective memory complaints in the Australian population. American Journal of Geriatric Psychiatry, doi: 10.1016/j.jagp.2013.04.004.Google Scholar
Meyers, J. E. and Meyers, K. R. (1995). Rey Complex Figure Test and Recognition Trial: Professional Manual. Lutz, FL: Psychological Assessment Resource, Inc. Google Scholar
Morris, J. C. (1993). The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology, 43, 2412–2414.Google ScholarPubMed
Morris, J. C. et al. (2012). Developing an international network for Alzheimer research: the Dominantly Inherited Alzheimer Network. Clinical Investigation (London), 2, 975–984.Google Scholar
Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G. and Kokmen, E. (1999). Mild cognitive impairment: clinical characterization and outcome. Archives of Neurology, 56, 303–308.Google Scholar
Reiman, E. M. et al. (2011). Alzheimer's Prevention Initiative: a plan to accelerate the evaluation of presymptomatic treatments. Journal of Alzheimer's Disease, 26, 321–329.Google Scholar
Rowe, C. C. et al. (2010). Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging. Imaging beta-amyloid burden in aging and dementia. Neurobiology of Aging, 31, 1275–1283.Google Scholar
Savage, G. (2010). Neuropsychological assessment of dementia. In Ames, D., Burns, A. and O'Brien, J. (eds.), Dementia, 4th edn. (pp. 61–67). London: Hodder.Google Scholar
Saxton, J. et al. (2000). Normative data on the Boston Naming Test and two equivalent 30-item short forms. Clinical Neuropsychology, 14, 526–534.Google Scholar
Schneider, L. S., Insel, P. S., Weiner, M. W. and the Alzheimer's Disease Neuroimaging Initiative (2011). Treatment with cholinesterase inhibitors and memantine in patients in the Alzheimer's Disease Neuroimaging Initiative. Archives of Neurology, 68, 58–66.Google Scholar
Sheikh, J. I. and Yesavage, J. A. (1986). Geriatric Depression Scale (GDS): recent evidence and development of a shorter version. In Clinical Gerontology: Guide to Assessment and Intervention (pp. 165–173). New York: The Haworth Press.Google Scholar
Slavin, M. J. et al. (2010). Prevalence and predictors of “subjective cognitive complaints” in the Sydney Memory and Ageing Study. American Journal of Geriatric Psychiatry, 18, 701–710.Google Scholar
Snaith, R. P. and Zigmond, A. S. (1986). The hospital anxiety and depression scale. British Medical Journal (Clinical Research Ed.), 292, 344.Google Scholar
Sona, A. et al. (2012). Predictors of rapid decline in Alzheimer's disease: results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of ageing. International Psychogeriatrics, 24, 197–204.Google Scholar
Sperling, R. A. et al. (2011). Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers & Dementia, 7, 280–292.Google Scholar
Strauss, E., Sherman, E. M. S. and Spreen, O. (2006). A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary, 3rd edn. New York: Oxford University Press.Google Scholar
Wechsler, D. (1945). A standardised memory scale for clinical use. Journal of Psychology, 19, 87–95.Google Scholar
Wechsler, D. (1997). Wechsler Adult Intelligence Scale–Third Edition (WAIS-III). San Antonio, TX: The Psychological Corporation.Google Scholar
Wechsler, D. (2001). Wechsler Test of Adult Reading: Examiner's Manual. San Antonio, Texas: The Psychological Corporation.Google Scholar
Winblad, B. et al. (2004). Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. Journal of Internal Medicine, 256, 240–246.Google Scholar
World Health Organization (1992). ICD-10 Classifications of Mental and Behavioural Disorder: Clinical Descriptions and Diagnostic Guidelines. Geneva: World Health Organization.Google Scholar
Zigmond, A. S. and Snaith, R. P. (1983). The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica, 67, 361–370.Google Scholar